Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. (INDP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · INDP · as of Jun 8, 2026
Key Statistics
Explore Indaptus Therapeutics, Inc. Data
indp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
indp competitorsINDP
ATXI
AZTR
GTBP
LIPO
NKGNStock Performance
Full HistoryAbout Indaptus Therapeutics, Inc.
Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral inf…
what is indaptus therapeutics, inc. · indp stock overview · indaptus therapeutics, inc. company profile · who is indaptus therapeutics, inc. ceo · indp NASDAQ · indaptus therapeutics, inc. headquarters · indaptus therapeutics, inc. business segments
About Stock Overview & Key Data
Indaptus Therapeutics, Inc. (INDP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Aug 4, 2015. As of the latest trading session, INDP stock price is $2.10, with a market capitalization of $3.7M. The stock has returned -78.10% over the past 12 months and -27.84% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Indaptus Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Indaptus Therapeutics, Inc. reported revenue of — and net income of -$20.8M. For detailed data — including Indaptus Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Indaptus Therapeutics, Inc. (INDP) stock price is $2.10. The stock is traded on NASDAQ under the ticker symbol INDP. The 52-week range is $0.92 – $19.91.